Literature DB >> 3721787

Sucrose permeability of the blood-retinal and blood-brain barriers. Effects of diabetes, hypertonicity, and iodate.

S R Ennis, A L Betz.   

Abstract

The permeabilities of the blood-retinal (BRB) and blood-brain (BBB) barriers to sucrose were determined simultaneously using an intravenous injection technique in the rat. The method involved direct sampling of retinal tissue in order to avoid errors caused by sucrose penetration across other components of the blood-ocular barrier. The permeability X surface area (PS) product for the BRB was approximately four times greater than for the BBB. Intracarotid infusion of a hypertonic arabinose solution resulted in a dose-dependent increase in the permeability of both barrier systems. In contrast, 24 hr after treatment of animals with iodate, the PS product for the BRB but not the BBB was increased. The permeability of the blood-retinal barrier to sucrose was measured in normal and 2-, 6-, and 20-week streptozocin diabetic rats. The BRB was unaffected at 2 and 6 weeks of diabetes, and showed only a small increase in permeability at 20 weeks. Our results suggest that alterations in the blood-ocular barrier in early diabetes do not result from an increased passive permeability of the BRB. The method described should permit direct comparison of BRB and BBB permeabilities to a variety of compounds under various conditions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3721787

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  17 in total

1.  Labelling of retinal microglial cells following an intravenous injection of a fluorescent dye into rats of different ages.

Authors:  X X Zeng; Y K Ng; E A Ling
Journal:  J Anat       Date:  2000-02       Impact factor: 2.610

Review 2.  In vivo methods to study uptake of nanoparticles into the brain.

Authors:  Inge van Rooy; Serpil Cakir-Tascioglu; Wim E Hennink; Gert Storm; Raymond M Schiffelers; Enrico Mastrobattista
Journal:  Pharm Res       Date:  2010-10-07       Impact factor: 4.200

3.  Quantitative assessment of the permeability of the rat blood-retinal barrier to small water-soluble non-electrolytes.

Authors:  S L Lightman; A G Palestine; S I Rapoport; E Rechthand
Journal:  J Physiol       Date:  1987-08       Impact factor: 5.182

4.  Increased blood-brain barrier permeability and altered tight junctions in experimental diabetes in the rat: contribution of hyperglycaemia and matrix metalloproteinases.

Authors:  B T Hawkins; T F Lundeen; K M Norwood; H L Brooks; R D Egleton
Journal:  Diabetologia       Date:  2006-12-02       Impact factor: 10.122

5.  Quantitative receptor autoradiographic analysis for angiotensin II receptors in bovine retinal microvessels: quantitation with radioluminography.

Authors:  T Sato; M Niwa; A Himeno; K Tsutsumi; T Amemiya
Journal:  Cell Mol Neurobiol       Date:  1993-06       Impact factor: 5.046

6.  Transport into retina measured by short vascular perfusion in the rat.

Authors:  J A Gratton; S L Lightman; M W Bradbury
Journal:  J Physiol       Date:  1993-10       Impact factor: 5.182

7.  Lipophilicity and transporter influence on blood-retinal barrier permeability: a comparison with blood-brain barrier permeability.

Authors:  Ken-ichi Hosoya; Atsushi Yamamoto; Shin-ichi Akanuma; Masanori Tachikawa
Journal:  Pharm Res       Date:  2010-09-22       Impact factor: 4.200

Review 8.  Effects of diabetes on brain metabolism--is brain glycogen a significant player?

Authors:  Helle M Sickmann; Helle S Waagepetersen
Journal:  Metab Brain Dis       Date:  2014-04-29       Impact factor: 3.584

9.  The effect of sodium iodate on the blood-retinal and blood-brain barriers.

Authors:  J Taarnhöj; A Alm
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

10.  Manganese-enhanced MRI studies of alterations of intraretinal ion demand in models of ocular injury.

Authors:  Bruce A Berkowitz; Robin Roberts; Hongmei Luan; David Bissig; Bang V Bui; Marius Gradianu; David J Calkins; Algis J Vingrys
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.